Kevin M. Picardat

Array ( [id] => 7089634 [patent_doc_number] => 20050009747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'High purity lipopeptides' [patent_app_type] => utility [patent_app_number] => 10/747485 [patent_app_country] => US [patent_app_date] => 2003-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20475 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009747.pdf [firstpage_image] =>[orig_patent_app_number] => 10747485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 274088 [patent_doc_number] => 07560252 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-14 [patent_title] => 'Borrelidin-producing polyketide synthase and its use' [patent_app_type] => utility [patent_app_number] => 10/534210 [patent_app_country] => US [patent_app_date] => 2003-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 39093 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/560/07560252.pdf [firstpage_image] =>[orig_patent_app_number] => 10534210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 278004 [patent_doc_number] => 07557079 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-07 [patent_title] => 'Metalloprotease proteins' [patent_app_type] => utility [patent_app_number] => 10/539847 [patent_app_country] => US [patent_app_date] => 2003-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24399 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/557/07557079.pdf [firstpage_image] =>[orig_patent_app_number] => 10539847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7285913 [patent_doc_number] => 20040146527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Pertussis toxin gene: cloning and expression of protective antigen' [patent_app_type] => new [patent_app_number] => 10/744736 [patent_app_country] => US [patent_app_date] => 2003-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10862 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146527.pdf [firstpage_image] =>[orig_patent_app_number] => 10744736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 383110 [patent_doc_number] => 07307062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-11 [patent_title] => 'Method for treating a mental disorder' [patent_app_type] => utility [patent_app_number] => 10/741377 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8468 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/307/07307062.pdf [firstpage_image] =>[orig_patent_app_number] => 10741377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368402 [patent_doc_number] => 20090305961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Novel chimeric plasminogen activators and their pharmaceutical use' [patent_app_type] => utility [patent_app_number] => 10/583785 [patent_app_country] => US [patent_app_date] => 2003-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7477 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305961.pdf [firstpage_image] =>[orig_patent_app_number] => 10583785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7334959 [patent_doc_number] => 20040132138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Nucleic acid encoding recombinant salmon calcitonin, expression vector thereof, and method for producing recombinant salmon calcitonin therewith' [patent_app_type] => new [patent_app_number] => 10/737482 [patent_app_country] => US [patent_app_date] => 2003-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3963 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132138.pdf [firstpage_image] =>[orig_patent_app_number] => 10737482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 795645 [patent_doc_number] => 07429561 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-30 [patent_title] => 'Method for stimulating cell growth using sponge protein hydrolysates' [patent_app_type] => utility [patent_app_number] => 10/736067 [patent_app_country] => US [patent_app_date] => 2003-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6043 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/429/07429561.pdf [firstpage_image] =>[orig_patent_app_number] => 10736067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 575683 [patent_doc_number] => 07459522 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-02 [patent_title] => 'Peptide dimers as agonists of the erythropoietin (EPO) receptor, and associated methods of synthesis and use' [patent_app_type] => utility [patent_app_number] => 10/737245 [patent_app_country] => US [patent_app_date] => 2003-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11825 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/459/07459522.pdf [firstpage_image] =>[orig_patent_app_number] => 10737245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 917216 [patent_doc_number] => 07323443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-29 [patent_title] => 'Lactoferrin in the reduction of pain' [patent_app_type] => utility [patent_app_number] => 10/733621 [patent_app_country] => US [patent_app_date] => 2003-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8162 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/323/07323443.pdf [firstpage_image] =>[orig_patent_app_number] => 10733621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677202 [patent_doc_number] => 20040152624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Oral lactoferrin in the treatment of sepsis' [patent_app_type] => new [patent_app_number] => 10/728521 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13503 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152624.pdf [firstpage_image] =>[orig_patent_app_number] => 10728521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7209007 [patent_doc_number] => 20040087776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Methods for producing factor VIII proteins' [patent_app_type] => new [patent_app_number] => 10/728242 [patent_app_country] => US [patent_app_date] => 2003-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4685 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087776.pdf [firstpage_image] =>[orig_patent_app_number] => 10728242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7172079 [patent_doc_number] => 20050203030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Novel effectors of dipeptidyl peptidase IV' [patent_app_type] => utility [patent_app_number] => 10/727209 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5365 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20050203030.pdf [firstpage_image] =>[orig_patent_app_number] => 10727209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7168705 [patent_doc_number] => 20040077527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Purified insulin composition' [patent_app_type] => new [patent_app_number] => 10/719552 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3440 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077527.pdf [firstpage_image] =>[orig_patent_app_number] => 10719552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275664 [patent_doc_number] => 20040235115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Compositions and methods for treating thrombotic disorders' [patent_app_type] => new [patent_app_number] => 10/715981 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7536 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235115.pdf [firstpage_image] =>[orig_patent_app_number] => 10715981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 532096 [patent_doc_number] => 07172764 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-06 [patent_title] => 'Rescue agents for treating botulinum toxin intoxications' [patent_app_type] => utility [patent_app_number] => 10/715810 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 11 [patent_no_of_words] => 18250 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/172/07172764.pdf [firstpage_image] =>[orig_patent_app_number] => 10715810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7362383 [patent_doc_number] => 20040091578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Stabilization of hypoallergenic, hyperdigestible previously reduced proteins' [patent_app_type] => new [patent_app_number] => 10/698824 [patent_app_country] => US [patent_app_date] => 2003-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 51494 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20040091578.pdf [firstpage_image] =>[orig_patent_app_number] => 10698824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921317 [patent_doc_number] => 20060239993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Drug containing angiotensin convertase' [patent_app_type] => utility [patent_app_number] => 10/532986 [patent_app_country] => US [patent_app_date] => 2003-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7109 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20060239993.pdf [firstpage_image] =>[orig_patent_app_number] => 10532986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7200614 [patent_doc_number] => 20050042300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Use of colostrinin, constituent peptides thereof, and analogs thereof as inhibitors of apoptosis and other cellular damage' [patent_app_type] => utility [patent_app_number] => 10/691330 [patent_app_country] => US [patent_app_date] => 2003-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10188 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042300.pdf [firstpage_image] =>[orig_patent_app_number] => 10691330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7434142 [patent_doc_number] => 20040266681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Use of colostrinin,constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules' [patent_app_type] => new [patent_app_number] => 10/691157 [patent_app_country] => US [patent_app_date] => 2003-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10499 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266681.pdf [firstpage_image] =>[orig_patent_app_number] => 10691157 [rel_patent_id] =>[rel_patent_doc_number] =>)